Ophthalmology
Stealth Biotherapeutics Inc. is engaged in clinical research focused on dry age-related macular degeneration, a progressive retinal disorder affecting central vision and macular structure.
- Dry Age-Related Macular Degeneration
- Retinal Disease
- Macular Degeneration
The sponsor’s research interest centers on vision-related outcomes and the treatment of degenerative eye conditions with unmet therapeutic need.
Retinal Therapeutics
The company’s clinical activity includes investigation of elamipretide in the context of retinal preservation and functional support in dry AMD.
- Retinal Function
- Macular Health
- Visual Impairment
This area reflects interest in therapies aimed at slowing retinal decline and addressing structural and functional changes in the macula.
Rare and Chronic Eye Disorders
Its research portfolio includes a condition with chronic progression and limited treatment options, placing emphasis on long-term disease management in ophthalmic care.
- Chronic Ophthalmic Disease
- Degenerative Eye Conditions
- Age-Related Vision Loss
Clinical interest in this domain supports the development of interventions for patients with ongoing loss of central vision.
